To validate our pH2AX findings and to further address the presence of DNA damage or DNA damage response, we probed tumor sections with a primary 53BP1 antibody and counted the fraction of cells with multiple 53BP1 nuclear foci (Figure 3B). This evidence concerns the gene TP53BP1 and neoplasm.